Tenet Healthcare price target raised to $150 from $126 at Deutsche Bank

Deutsche Bank raised the firm’s price target on Tenet Healthcare to $150 from $126 and keeps a Buy rating on the shares. The analyst believes taking profits with the shares up 74% year-to-date would be the wrong move at this point. Tenet is in the middle of a multi-year transformation and there could be plenty of equity upside left, the analyst tells investors in a research note. The firm says the company increased guidance solely based on supplemental payments and increased acquisition activity, and not due to outperformance of core operations.